These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 11381055)

  • 1. Increased human scleral permeability with prostaglandin exposure.
    Kim JW; Lindsey JD; Wang N; Weinreb RN
    Invest Ophthalmol Vis Sci; 2001 Jun; 42(7):1514-21. PubMed ID: 11381055
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prostaglandin FP agonists alter metalloproteinase gene expression in sclera.
    Weinreb RN; Lindsey JD; Marchenko G; Marchenko N; Angert M; Strongin A
    Invest Ophthalmol Vis Sci; 2004 Dec; 45(12):4368-77. PubMed ID: 15557445
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhancement of scleral macromolecular permeability with prostaglandins.
    Weinreb RN
    Trans Am Ophthalmol Soc; 2001; 99():319-43. PubMed ID: 11797317
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhanced FGF-2 movement through human sclera after exposure to latanoprost.
    Aihara M; Lindsey JD; Weinreb RN
    Invest Ophthalmol Vis Sci; 2001 Oct; 42(11):2554-9. PubMed ID: 11581197
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Direct matrix metalloproteinase enhancement of transscleral permeability.
    Lindsey JD; Crowston JG; Tran A; Morris C; Weinreb RN
    Invest Ophthalmol Vis Sci; 2007 Feb; 48(2):752-5. PubMed ID: 17251474
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Latanoprost and matrix metalloproteinase-1 in human choroid organ cultures.
    Wang N; Lindsey JD; Angert M; Weinreb RN
    Curr Eye Res; 2001 Mar; 22(3):198-207. PubMed ID: 11462156
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro human scleral permeability of fluorescein, dexamethasone-fluorescein, methotrexate-fluorescein and rhodamine 6G and the use of a coated coil as a new drug delivery system.
    Cruysberg LP; Nuijts RM; Geroski DH; Koole LH; Hendrikse F; Edelhauser HF
    J Ocul Pharmacol Ther; 2002 Dec; 18(6):559-69. PubMed ID: 12537682
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human scleral permeability. Effects of age, cryotherapy, transscleral diode laser, and surgical thinning.
    Olsen TW; Edelhauser HF; Lim JI; Geroski DH
    Invest Ophthalmol Vis Sci; 1995 Aug; 36(9):1893-903. PubMed ID: 7543465
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diffusion of high molecular weight compounds through sclera.
    Ambati J; Canakis CS; Miller JW; Gragoudas ES; Edwards A; Weissgold DJ; Kim I; Delori FC; Adamis AP
    Invest Ophthalmol Vis Sci; 2000 Apr; 41(5):1181-5. PubMed ID: 10752958
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diffusion of macromolecules through sclera.
    Miao H; Wu BD; Tao Y; Li XX
    Acta Ophthalmol; 2013 Feb; 91(1):e1-6. PubMed ID: 22998133
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute effects of PGF2alpha on MMP-2 secretion from human ciliary muscle cells: a PKC- and ERK-dependent process.
    Husain S; Jafri F; Crosson CE
    Invest Ophthalmol Vis Sci; 2005 May; 46(5):1706-13. PubMed ID: 15851572
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The influence of intraocular pressure on the transscleral diffusion of high-molecular-weight compounds.
    Cruysberg LP; Nuijts RM; Geroski DH; Gilbert JA; Hendrikse F; Edelhauser HF
    Invest Ophthalmol Vis Sci; 2005 Oct; 46(10):3790-4. PubMed ID: 16186364
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of benzalkonium chloride on transscleral drug delivery.
    Okabe K; Kimura H; Okabe J; Kato A; Shimizu H; Ueda T; Shimada S; Ogura Y
    Invest Ophthalmol Vis Sci; 2005 Feb; 46(2):703-8. PubMed ID: 15671302
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Scleral hydraulic conductivity and macromolecular diffusion in patients with uveal effusion syndrome.
    Jackson TL; Hussain A; Morley AM; Sullivan PM; Hodgetts A; El-Osta A; Hillenkamp J; Charles SJ; Sheard R; Williamson TH; Kumar A; Laidlaw DA; Woon WH; Costen MJ; Luff AJ; Marshall J
    Invest Ophthalmol Vis Sci; 2008 Nov; 49(11):5033-40. PubMed ID: 18552396
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of prostaglandin F2alpha and latanoprost on phosphoinositide turnover, myosin light chain phosphorylation and contraction in cat iris sphincter.
    Ansari HR; Davis AM; Kaddour-Djebbar I; Abdel-Latif AA
    J Ocul Pharmacol Ther; 2003 Jun; 19(3):217-31. PubMed ID: 12828840
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Penetration of natural prostaglandins and their ester prodrugs and analogs across human ocular tissues in vitro.
    Madhu C; Rix P; Nguyen T; Chien DS; Woodward DF; Tang-Liu DD
    J Ocul Pharmacol Ther; 1998 Oct; 14(5):389-99. PubMed ID: 9811228
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prostaglandins increase matrix metalloproteinase release from human ciliary smooth muscle cells.
    Weinreb RN; Kashiwagi K; Kashiwagi F; Tsukahara S; Lindsey JD
    Invest Ophthalmol Vis Sci; 1997 Dec; 38(13):2772-80. PubMed ID: 9418730
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro effects of insulin and RPE on choroidal and scleral components of eye growth in chicks.
    Sheng C; Zhu X; Wallman J
    Exp Eye Res; 2013 Nov; 116():439-48. PubMed ID: 23994438
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Scleral permeability varies by mouse strain and is decreased by chronic experimental glaucoma.
    Pease ME; Oglesby EN; Cone-Kimball E; Jefferys JL; Steinhart MR; Kim AJ; Hanes J; Quigley HA
    Invest Ophthalmol Vis Sci; 2014 Apr; 55(4):2564-73. PubMed ID: 24557355
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exogenous collagen cross-linking reduces scleral permeability: modeling the effects of age-related cross-link accumulation.
    Stewart JM; Schultz DS; Lee OT; Trinidad ML
    Invest Ophthalmol Vis Sci; 2009 Jan; 50(1):352-7. PubMed ID: 18708616
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.